Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel-arm, Double-blind, Randomized, Placebo-controlled, Dose-ranging Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of AV7909 in Healthy Adults

NCT01263691 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT01263691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01263691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel-arm, Double-blind, Randomized, Placebo-controlled, Dose-ranging Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of AV7909 in Healthy Adults
Lead sponsor
Emergent BioSolutions
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2010
Completion date
June 30, 2012
Enrollment
105 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bacillus anthracis (anthrax) infection